Document is current
Any future updates will be listed below
-
Authors
Ranasinghe, Kamalini G. https://orcid.org/0000-0002-4217-8785
Kudo, Kiwamu https://orcid.org/0000-0002-5732-7229
Syed, Faatimah
Yballa, Claire
Kramer, Joel H.
Miller, Bruce L.
Rankin, Katherine P. https://orcid.org/0000-0002-3611-0848
Garcia, Paul A.
Kirsch, Heidi E. https://orcid.org/0000-0002-3144-2085
Vossel, Keith
Jagust, William https://orcid.org/0000-0002-4458-113X
Rabinovici, Gil D. https://orcid.org/0000-0002-3626-4265
Nagarajan, Srikantan S.
-
Funding
Funding for this research was provided by:
Larry L. Hillblom Foundation (2019-A-013-SUP)
Alzheimer's Association (AARG-21-849773)
- License Information
-
More Information
Article History
Received: 17 March 2025
Accepted: 30 July 2025
First Online: 26 August 2025
Competing interests
: K.G.R., K.K., K.P.R., P.A.G., H.E.K., C.Y., F.S., K.V., G.D.R., J.H.K. and W.J. declare no competing interests relevant to this work. S.S.N. serves as a founding board member in Hippoclinic Inc., as a private consultant to MEGIN Inc. and is the PI for an industry contract from Ricoh MEG USA. B.L.M. has the following disclosures: serves as Medical Director for the John Douglas French Foundation; Scientific Director for the Tau Consortium; Director/Medical Advisory Board of the Larry L. Hillblom Foundation; and Scientific Advisory Board Member for the National Institute for Health Research Cambridge Biomedical Research Center and its subunit, the Biomedical Research Unit in Dementia, UK.
